Vol.31 No.4 Contents
 |
Hideyuki Okano Editor in Chief Inflammation and Regeneration Cover [  PDF(382KB)] |
Review Article
| 1．Molecular and cellular basis for cardiac regeneration |
334-340
|
|
I. Shiojima and I. Komuro
|
|
|
[PDF (135KB)] |
Special Issue: "Novel targeted therapies"
| 2．Recent progress in small molecular products for the treatment of joint and bone diseases: an over view |
341-343
|
|
Y. Tanaka and N. Miyasaka
|
|
|
[PDF (45KB)] |
| 3．Denosumab for the treatment of joint and bone diseases |
344-348
|
|
Y. Tanaka
|
|
|
[PDF (99KB)] |
| 4．JAK inhibitor: tofacitinib, a new disease modifying anti-rheumatic drug |
349-353
|
|
K. Yamaoka, S. Kubo, K. Sonomoto, K. Maeshima, and Y. Tanaka
|
|
|
[PDF (119KB)] |
| 5．Potential molecular targets for suppressing Th17 development |
354-360
|
|
K. Okamoto and H. Takayanagi
|
|
|
[PDF (354KB)] |
Mini Review
| 6．Immune cells and iPS cells |
361-364
|
|
H. Wada and K. Seino
|
|
|
[PDF (52KB)] |
| 7．Cytokines and chemokines as therapeutic targets for ischemic kidney injury |
365-369
|
|
K. Furuichi, T. Wada and S. Kaneko
|
|
|
[PDF (444KB)] |
| 8．Phospholipase Cε as a potential molecular target for anti-inflammatory therapy and cancer prevention |
370-374
|
|
H. Edamatsu, N. Takenaka, L. Hu and T. Kataoka
|
|
|
[PDF (92KB)] |
| 9．Effect of antimicrobial cathelicidin peptides on the endothelial cell apoptosis |
375-381
|
|
Kaori Suzuki and Isao Nagaoka
|
|
|
[PDF (182KB)] |